Investor insights
Sectors invested in
Funding rounds participated in
$43M sweet spot round size
Most of their 64 investments are in rounds between $16M and $90M
Investor type
Basic info
Industry
Sectors
Date founded
2016
Investments made
Outpace Bio raised $25M on March 23, 2023
Investors: Bristol-Myers Squibb, UK, ARTIS Ventures, Civilization Ventures, Playground Global and Sahsen Ventures, LLC
Monod Bio raised $25M on August 15, 2022
Investors: Washington Research Foundation, Global Health Investment Fund, Cercano Management, Pack Ventures and Sahsen Ventures, LLC
Terray Therapeutics raised $60M on February 15, 2022
Investors: Goldcrest Capital, Digitalis Ventures, XTX Ventures, Greentrail Capital, KdT Ventures, Two Sigma Ventures, Madrona Venture Group and Sahsen Ventures, LLC
HilleVax raised $135M on September 8, 2021
Investors: Greenspring Associates, Qiming Venture Partners USA, Frazier Healthcare Partners, Richard King Mellon Foundation, Samsara BioCapital, Perceptive Advisors, Lightspeed Venture Partners, RA Capital Management, L.P. and Sahsen Ventures, LLC
Dyno Therapeutics raised $100M on May 6, 2021
Investors: Obvious Ventures, KdT Ventures, Lux Capital, Andreessen Horowitz, Polaris Partners, Casdin Capital, LLC, CRV, GV and Sahsen Ventures, LLC
Outpace Bio raised $30M on March 31, 2021
Investors: ARTIS Ventures, Washington Research Foundation, Abstract Ventures, Civilization Ventures, Playground Global, Lyell Immunopharma and Sahsen Ventures, LLC
Inspire raised undisclosed on January 1, 2021
Investors: Sahsen Ventures, LLC
ELEGEN raised undisclosed on July 30, 2020
Investors: Alix Ventures and Sahsen Ventures, LLC
Athira Pharma raised $85M on June 4, 2020
Investors: RTW Investments, LP, Logos Global Management, LP, Surveyor Capital, Viking Global Investors, Perceptive Advisors and Sahsen Ventures, LLC
Kriya Therapeutics raised $81M on May 12, 2020
Investors: Transhuman Capital, Narya, Foresite Capital, Dexcel Pharma, Amplo, JDRF T1D Fund, QVT Financial LLP and Sahsen Ventures, LLC